Akebia Therapeutics(AKBA) - 2025 FY - Earnings Call Transcript

Akebia Therapeutics (AKBA) FY 2025 Conference May 20, 2025 02:30 PM ET Speaker0 Right. So I guess we can get started here. So my name is Matthew Caulfield. I'm a senior biotech analyst here at H. C. Wainwright, and we're very excited to be welcoming Akebia Therapeutics. We're joined by John Butler, CEO, and also Nick Grund, chief commercial officer. So thank you very much for joining us today, guys. Speaker1 Thanks for having us, Matt. Great to you. Speaker0 So maybe to start off, you could maybe give us an ...